The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Estrogen and Progesterone API Market Research Report 2025
Synopsis
The global Estrogen and Progesterone API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Estrogen and Progesterone API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Estrogen and Progesterone API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Estrogen and Progesterone API include Pfizer, EUROAPI, Symbiotec, Valdepharm (Fareva), Gonane Pharma, Aspen API, Gedeon Richter, Zhejiang Xianju Pharmaceutical, Humanwell Healthcare, Hunan Norchem Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Estrogen and Progesterone API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Estrogen and Progesterone API.
The Estrogen and Progesterone API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Estrogen and Progesterone API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Estrogen and Progesterone API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
EUROAPI
Symbiotec
Valdepharm (Fareva)
Gonane Pharma
Aspen API
Gedeon Richter
Zhejiang Xianju Pharmaceutical
Humanwell Healthcare
Hunan Norchem Pharmaceutical
Zhejiang Xianju Xianle Pharmaceutical
Segment by Type
Estrogens
Progestins
Segment by Application
Oral Preparation
Topical Preparations
Injection
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Estrogen and Progesterone API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Estrogen and Progesterone API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Estrogen and Progesterone API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Estrogen and Progesterone API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Estrogen and Progesterone API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Estrogen and Progesterone API include Pfizer, EUROAPI, Symbiotec, Valdepharm (Fareva), Gonane Pharma, Aspen API, Gedeon Richter, Zhejiang Xianju Pharmaceutical, Humanwell Healthcare, Hunan Norchem Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Estrogen and Progesterone API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Estrogen and Progesterone API.
The Estrogen and Progesterone API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Estrogen and Progesterone API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Estrogen and Progesterone API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
EUROAPI
Symbiotec
Valdepharm (Fareva)
Gonane Pharma
Aspen API
Gedeon Richter
Zhejiang Xianju Pharmaceutical
Humanwell Healthcare
Hunan Norchem Pharmaceutical
Zhejiang Xianju Xianle Pharmaceutical
Segment by Type
Estrogens
Progestins
Segment by Application
Oral Preparation
Topical Preparations
Injection
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Estrogen and Progesterone API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Estrogen and Progesterone API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Estrogen and Progesterone API Market Overview
1.1 Product Definition
1.2 Estrogen and Progesterone API by Type
1.2.1 Global Estrogen and Progesterone API Market Value Comparison by Type (2024-2030)
1.2.2 Estrogens
1.2.3 Progestins
1.3 Estrogen and Progesterone API by Application
1.3.1 Global Estrogen and Progesterone API Market Value by Application (2024-2030)
1.3.2 Oral Preparation
1.3.3 Topical Preparations
1.3.4 Injection
1.4 Global Estrogen and Progesterone API Market Size Estimates and Forecasts
1.4.1 Global Estrogen and Progesterone API Revenue 2019-2030
1.4.2 Global Estrogen and Progesterone API Sales 2019-2030
1.4.3 Global Estrogen and Progesterone API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Estrogen and Progesterone API Market Competition by Manufacturers
2.1 Global Estrogen and Progesterone API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Estrogen and Progesterone API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Estrogen and Progesterone API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Estrogen and Progesterone API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Estrogen and Progesterone API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Estrogen and Progesterone API, Product Type & Application
2.7 Global Key Manufacturers of Estrogen and Progesterone API, Date of Enter into This Industry
2.8 Global Estrogen and Progesterone API Market Competitive Situation and Trends
2.8.1 Global Estrogen and Progesterone API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Estrogen and Progesterone API Players Market Share by Revenue
2.8.3 Global Estrogen and Progesterone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Estrogen and Progesterone API Market Scenario by Region
3.1 Global Estrogen and Progesterone API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Estrogen and Progesterone API Sales by Region: 2019-2030
3.2.1 Global Estrogen and Progesterone API Sales by Region: 2019-2024
3.2.2 Global Estrogen and Progesterone API Sales by Region: 2025-2030
3.3 Global Estrogen and Progesterone API Revenue by Region: 2019-2030
3.3.1 Global Estrogen and Progesterone API Revenue by Region: 2019-2024
3.3.2 Global Estrogen and Progesterone API Revenue by Region: 2025-2030
3.4 North America Estrogen and Progesterone API Market Facts & Figures by Country
3.4.1 North America Estrogen and Progesterone API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Estrogen and Progesterone API Sales by Country (2019-2030)
3.4.3 North America Estrogen and Progesterone API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Estrogen and Progesterone API Market Facts & Figures by Country
3.5.1 Europe Estrogen and Progesterone API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Estrogen and Progesterone API Sales by Country (2019-2030)
3.5.3 Europe Estrogen and Progesterone API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Estrogen and Progesterone API Market Facts & Figures by Region
3.6.1 Asia Pacific Estrogen and Progesterone API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Estrogen and Progesterone API Sales by Region (2019-2030)
3.6.3 Asia Pacific Estrogen and Progesterone API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Estrogen and Progesterone API Market Facts & Figures by Country
3.7.1 Latin America Estrogen and Progesterone API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Estrogen and Progesterone API Sales by Country (2019-2030)
3.7.3 Latin America Estrogen and Progesterone API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Estrogen and Progesterone API Market Facts & Figures by Country
3.8.1 Middle East and Africa Estrogen and Progesterone API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Estrogen and Progesterone API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Estrogen and Progesterone API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Estrogen and Progesterone API Sales by Type (2019-2030)
4.1.1 Global Estrogen and Progesterone API Sales by Type (2019-2024)
4.1.2 Global Estrogen and Progesterone API Sales by Type (2025-2030)
4.1.3 Global Estrogen and Progesterone API Sales Market Share by Type (2019-2030)
4.2 Global Estrogen and Progesterone API Revenue by Type (2019-2030)
4.2.1 Global Estrogen and Progesterone API Revenue by Type (2019-2024)
4.2.2 Global Estrogen and Progesterone API Revenue by Type (2025-2030)
4.2.3 Global Estrogen and Progesterone API Revenue Market Share by Type (2019-2030)
4.3 Global Estrogen and Progesterone API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Estrogen and Progesterone API Sales by Application (2019-2030)
5.1.1 Global Estrogen and Progesterone API Sales by Application (2019-2024)
5.1.2 Global Estrogen and Progesterone API Sales by Application (2025-2030)
5.1.3 Global Estrogen and Progesterone API Sales Market Share by Application (2019-2030)
5.2 Global Estrogen and Progesterone API Revenue by Application (2019-2030)
5.2.1 Global Estrogen and Progesterone API Revenue by Application (2019-2024)
5.2.2 Global Estrogen and Progesterone API Revenue by Application (2025-2030)
5.2.3 Global Estrogen and Progesterone API Revenue Market Share by Application (2019-2030)
5.3 Global Estrogen and Progesterone API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Estrogen and Progesterone API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Estrogen and Progesterone API Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 EUROAPI
6.2.1 EUROAPI Company Information
6.2.2 EUROAPI Description and Business Overview
6.2.3 EUROAPI Estrogen and Progesterone API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 EUROAPI Estrogen and Progesterone API Product Portfolio
6.2.5 EUROAPI Recent Developments/Updates
6.3 Symbiotec
6.3.1 Symbiotec Company Information
6.3.2 Symbiotec Description and Business Overview
6.3.3 Symbiotec Estrogen and Progesterone API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Symbiotec Estrogen and Progesterone API Product Portfolio
6.3.5 Symbiotec Recent Developments/Updates
6.4 Valdepharm (Fareva)
6.4.1 Valdepharm (Fareva) Company Information
6.4.2 Valdepharm (Fareva) Description and Business Overview
6.4.3 Valdepharm (Fareva) Estrogen and Progesterone API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Valdepharm (Fareva) Estrogen and Progesterone API Product Portfolio
6.4.5 Valdepharm (Fareva) Recent Developments/Updates
6.5 Gonane Pharma
6.5.1 Gonane Pharma Company Information
6.5.2 Gonane Pharma Description and Business Overview
6.5.3 Gonane Pharma Estrogen and Progesterone API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Gonane Pharma Estrogen and Progesterone API Product Portfolio
6.5.5 Gonane Pharma Recent Developments/Updates
6.6 Aspen API
6.6.1 Aspen API Company Information
6.6.2 Aspen API Description and Business Overview
6.6.3 Aspen API Estrogen and Progesterone API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aspen API Estrogen and Progesterone API Product Portfolio
6.6.5 Aspen API Recent Developments/Updates
6.7 Gedeon Richter
6.7.1 Gedeon Richter Company Information
6.7.2 Gedeon Richter Description and Business Overview
6.7.3 Gedeon Richter Estrogen and Progesterone API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Gedeon Richter Estrogen and Progesterone API Product Portfolio
6.7.5 Gedeon Richter Recent Developments/Updates
6.8 Zhejiang Xianju Pharmaceutical
6.8.1 Zhejiang Xianju Pharmaceutical Company Information
6.8.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.8.3 Zhejiang Xianju Pharmaceutical Estrogen and Progesterone API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zhejiang Xianju Pharmaceutical Estrogen and Progesterone API Product Portfolio
6.8.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.9 Humanwell Healthcare
6.9.1 Humanwell Healthcare Company Information
6.9.2 Humanwell Healthcare Description and Business Overview
6.9.3 Humanwell Healthcare Estrogen and Progesterone API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Humanwell Healthcare Estrogen and Progesterone API Product Portfolio
6.9.5 Humanwell Healthcare Recent Developments/Updates
6.10 Hunan Norchem Pharmaceutical
6.10.1 Hunan Norchem Pharmaceutical Company Information
6.10.2 Hunan Norchem Pharmaceutical Description and Business Overview
6.10.3 Hunan Norchem Pharmaceutical Estrogen and Progesterone API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hunan Norchem Pharmaceutical Estrogen and Progesterone API Product Portfolio
6.10.5 Hunan Norchem Pharmaceutical Recent Developments/Updates
6.11 Zhejiang Xianju Xianle Pharmaceutical
6.11.1 Zhejiang Xianju Xianle Pharmaceutical Company Information
6.11.2 Zhejiang Xianju Xianle Pharmaceutical Description and Business Overview
6.11.3 Zhejiang Xianju Xianle Pharmaceutical Estrogen and Progesterone API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zhejiang Xianju Xianle Pharmaceutical Estrogen and Progesterone API Product Portfolio
6.11.5 Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Estrogen and Progesterone API Industry Chain Analysis
7.2 Estrogen and Progesterone API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Estrogen and Progesterone API Production Mode & Process
7.4 Estrogen and Progesterone API Sales and Marketing
7.4.1 Estrogen and Progesterone API Sales Channels
7.4.2 Estrogen and Progesterone API Distributors
7.5 Estrogen and Progesterone API Customers
8 Estrogen and Progesterone API Market Dynamics
8.1 Estrogen and Progesterone API Industry Trends
8.2 Estrogen and Progesterone API Market Drivers
8.3 Estrogen and Progesterone API Market Challenges
8.4 Estrogen and Progesterone API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Estrogen and Progesterone API Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Estrogen and Progesterone API Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Estrogen and Progesterone API Market Competitive Situation by Manufacturers in 2023
Table 4. Global Estrogen and Progesterone API Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Estrogen and Progesterone API Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Estrogen and Progesterone API Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Estrogen and Progesterone API Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Estrogen and Progesterone API Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Estrogen and Progesterone API, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Estrogen and Progesterone API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Estrogen and Progesterone API, Product Type & Application
Table 12. Global Key Manufacturers of Estrogen and Progesterone API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Estrogen and Progesterone API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Estrogen and Progesterone API as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Estrogen and Progesterone API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Estrogen and Progesterone API Sales by Region (2019-2024) & (Tons)
Table 18. Global Estrogen and Progesterone API Sales Market Share by Region (2019-2024)
Table 19. Global Estrogen and Progesterone API Sales by Region (2025-2030) & (Tons)
Table 20. Global Estrogen and Progesterone API Sales Market Share by Region (2025-2030)
Table 21. Global Estrogen and Progesterone API Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Estrogen and Progesterone API Revenue Market Share by Region (2019-2024)
Table 23. Global Estrogen and Progesterone API Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Estrogen and Progesterone API Revenue Market Share by Region (2025-2030)
Table 25. North America Estrogen and Progesterone API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Estrogen and Progesterone API Sales by Country (2019-2024) & (Tons)
Table 27. North America Estrogen and Progesterone API Sales by Country (2025-2030) & (Tons)
Table 28. North America Estrogen and Progesterone API Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Estrogen and Progesterone API Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Estrogen and Progesterone API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Estrogen and Progesterone API Sales by Country (2019-2024) & (Tons)
Table 32. Europe Estrogen and Progesterone API Sales by Country (2025-2030) & (Tons)
Table 33. Europe Estrogen and Progesterone API Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Estrogen and Progesterone API Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Estrogen and Progesterone API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Estrogen and Progesterone API Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Estrogen and Progesterone API Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Estrogen and Progesterone API Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Estrogen and Progesterone API Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Estrogen and Progesterone API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Estrogen and Progesterone API Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Estrogen and Progesterone API Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Estrogen and Progesterone API Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Estrogen and Progesterone API Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Estrogen and Progesterone API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Estrogen and Progesterone API Sales by Country (2019-2024) & (Tons)
Table 47. Middle East and Africa Estrogen and Progesterone API Sales by Country (2025-2030) & (Tons)
Table 48. Middle East and Africa Estrogen and Progesterone API Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Estrogen and Progesterone API Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Estrogen and Progesterone API Sales (Tons) by Type (2019-2024)
Table 51. Global Estrogen and Progesterone API Sales (Tons) by Type (2025-2030)
Table 52. Global Estrogen and Progesterone API Sales Market Share by Type (2019-2024)
Table 53. Global Estrogen and Progesterone API Sales Market Share by Type (2025-2030)
Table 54. Global Estrogen and Progesterone API Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Estrogen and Progesterone API Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Estrogen and Progesterone API Revenue Market Share by Type (2019-2024)
Table 57. Global Estrogen and Progesterone API Revenue Market Share by Type (2025-2030)
Table 58. Global Estrogen and Progesterone API Price (US$/Kg) by Type (2019-2024)
Table 59. Global Estrogen and Progesterone API Price (US$/Kg) by Type (2025-2030)
Table 60. Global Estrogen and Progesterone API Sales (Tons) by Application (2019-2024)
Table 61. Global Estrogen and Progesterone API Sales (Tons) by Application (2025-2030)
Table 62. Global Estrogen and Progesterone API Sales Market Share by Application (2019-2024)
Table 63. Global Estrogen and Progesterone API Sales Market Share by Application (2025-2030)
Table 64. Global Estrogen and Progesterone API Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Estrogen and Progesterone API Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Estrogen and Progesterone API Revenue Market Share by Application (2019-2024)
Table 67. Global Estrogen and Progesterone API Revenue Market Share by Application (2025-2030)
Table 68. Global Estrogen and Progesterone API Price (US$/Kg) by Application (2019-2024)
Table 69. Global Estrogen and Progesterone API Price (US$/Kg) by Application (2025-2030)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Pfizer Estrogen and Progesterone API Product
Table 74. Pfizer Recent Developments/Updates
Table 75. EUROAPI Company Information
Table 76. EUROAPI Description and Business Overview
Table 77. EUROAPI Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. EUROAPI Estrogen and Progesterone API Product
Table 79. EUROAPI Recent Developments/Updates
Table 80. Symbiotec Company Information
Table 81. Symbiotec Description and Business Overview
Table 82. Symbiotec Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Symbiotec Estrogen and Progesterone API Product
Table 84. Symbiotec Recent Developments/Updates
Table 85. Valdepharm (Fareva) Company Information
Table 86. Valdepharm (Fareva) Description and Business Overview
Table 87. Valdepharm (Fareva) Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Valdepharm (Fareva) Estrogen and Progesterone API Product
Table 89. Valdepharm (Fareva) Recent Developments/Updates
Table 90. Gonane Pharma Company Information
Table 91. Gonane Pharma Description and Business Overview
Table 92. Gonane Pharma Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Gonane Pharma Estrogen and Progesterone API Product
Table 94. Gonane Pharma Recent Developments/Updates
Table 95. Aspen API Company Information
Table 96. Aspen API Description and Business Overview
Table 97. Aspen API Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Aspen API Estrogen and Progesterone API Product
Table 99. Aspen API Recent Developments/Updates
Table 100. Gedeon Richter Company Information
Table 101. Gedeon Richter Description and Business Overview
Table 102. Gedeon Richter Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Gedeon Richter Estrogen and Progesterone API Product
Table 104. Gedeon Richter Recent Developments/Updates
Table 105. Zhejiang Xianju Pharmaceutical Company Information
Table 106. Zhejiang Xianju Pharmaceutical Description and Business Overview
Table 107. Zhejiang Xianju Pharmaceutical Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Zhejiang Xianju Pharmaceutical Estrogen and Progesterone API Product
Table 109. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 110. Humanwell Healthcare Company Information
Table 111. Humanwell Healthcare Description and Business Overview
Table 112. Humanwell Healthcare Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Humanwell Healthcare Estrogen and Progesterone API Product
Table 114. Humanwell Healthcare Recent Developments/Updates
Table 115. Hunan Norchem Pharmaceutical Company Information
Table 116. Hunan Norchem Pharmaceutical Description and Business Overview
Table 117. Hunan Norchem Pharmaceutical Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Hunan Norchem Pharmaceutical Estrogen and Progesterone API Product
Table 119. Hunan Norchem Pharmaceutical Recent Developments/Updates
Table 120. Zhejiang Xianju Xianle Pharmaceutical Company Information
Table 121. Zhejiang Xianju Xianle Pharmaceutical Description and Business Overview
Table 122. Zhejiang Xianju Xianle Pharmaceutical Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Zhejiang Xianju Xianle Pharmaceutical Estrogen and Progesterone API Product
Table 124. Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Estrogen and Progesterone API Distributors List
Table 128. Estrogen and Progesterone API Customers List
Table 129. Estrogen and Progesterone API Market Trends
Table 130. Estrogen and Progesterone API Market Drivers
Table 131. Estrogen and Progesterone API Market Challenges
Table 132. Estrogen and Progesterone API Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Estrogen and Progesterone API
Figure 2. Global Estrogen and Progesterone API Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Estrogen and Progesterone API Market Share by Type: 2023 & 2030
Figure 4. Estrogens Product Picture
Figure 5. Progestins Product Picture
Figure 6. Global Estrogen and Progesterone API Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Estrogen and Progesterone API Market Share by Application: 2023 & 2030
Figure 8. Oral Preparation
Figure 9. Topical Preparations
Figure 10. Injection
Figure 11. Global Estrogen and Progesterone API Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Estrogen and Progesterone API Market Size (2019-2030) & (US$ Million)
Figure 13. Global Estrogen and Progesterone API Sales (2019-2030) & (Tons)
Figure 14. Global Estrogen and Progesterone API Average Price (US$/Kg) & (2019-2030)
Figure 15. Estrogen and Progesterone API Report Years Considered
Figure 16. Estrogen and Progesterone API Sales Share by Manufacturers in 2023
Figure 17. Global Estrogen and Progesterone API Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Estrogen and Progesterone API Players: Market Share by Revenue in Estrogen and Progesterone API in 2023
Figure 19. Estrogen and Progesterone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Estrogen and Progesterone API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Estrogen and Progesterone API Sales Market Share by Country (2019-2030)
Figure 22. North America Estrogen and Progesterone API Revenue Market Share by Country (2019-2030)
Figure 23. United States Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Estrogen and Progesterone API Sales Market Share by Country (2019-2030)
Figure 26. Europe Estrogen and Progesterone API Revenue Market Share by Country (2019-2030)
Figure 27. Germany Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Estrogen and Progesterone API Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Estrogen and Progesterone API Revenue Market Share by Region (2019-2030)
Figure 34. China Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Estrogen and Progesterone API Sales Market Share by Country (2019-2030)
Figure 42. Mexico Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Estrogen and Progesterone API Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Estrogen and Progesterone API Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Estrogen and Progesterone API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Estrogen and Progesterone API by Type (2019-2030)
Figure 52. Global Revenue Market Share of Estrogen and Progesterone API by Type (2019-2030)
Figure 53. Global Estrogen and Progesterone API Price (US$/Kg) by Type (2019-2030)
Figure 54. Global Sales Market Share of Estrogen and Progesterone API by Application (2019-2030)
Figure 55. Global Revenue Market Share of Estrogen and Progesterone API by Application (2019-2030)
Figure 56. Global Estrogen and Progesterone API Price (US$/Kg) by Application (2019-2030)
Figure 57. Estrogen and Progesterone API Value Chain
Figure 58. Estrogen and Progesterone API Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
